(Q35932382)

English

Cardiac cachexia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

Cardiac cachexia. (English)

1 reference

Europe PubMed Central

11 August 2017

author name string

Stefan D Anker

1

1 reference

Europe PubMed Central

11 August 2017

Wolfram Steinborn

2

1 reference

Europe PubMed Central

11 August 2017

Sabine Strassburg

3

1 reference

Europe PubMed Central

11 August 2017

language of work or name

0 references

publication date

1 January 2004

1 reference

Europe PubMed Central

11 August 2017

Annals of Medicine

1 reference

Europe PubMed Central

11 August 2017

36

1 reference

Europe PubMed Central

11 August 2017

7

1 reference

Europe PubMed Central

11 August 2017

518-529

1 reference

Europe PubMed Central

11 August 2017

Epidemiology, aetiology, and prognosis of heart failure

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Cardiac cachexia in early literature: a review of research prior to Medline

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators.

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

The syndrome of cardiac cachexia

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

THE PATHOGENESIS OF CARDIAC CACHEXIA.

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Gastrointestinal absorption studies in cardiac cachexia

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance.

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone.

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Plasma norepinephrine as an indicator of sympathetic neural activity in clinical cardiology

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Ventricular assist device in severe heart failure: effects on cytokines, complement and body weight

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Endotoxin and immune activation in chronic heart failure: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Cachexia: a therapeutic approach beyond cytokine antagonism

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocation

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

The endotoxin-lipoprotein hypothesis

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure.

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

The relationship between cholesterol and survival in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

IL-6: insights into novel biological activities

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients.

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Tumour necrosis factor in chronic heart failure: a peripheral view on pathogenesis, clinical manifestations and therapeutic implications

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Positional cloning of the mouse obese gene and its human homologue

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Hyperleptinaemia in chronic heart failure. Relationships with insulin

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Chronic heart failure and micronutrients

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Oxygen free radicals and congestive heart failure

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Cytokines, apoptosis and cachexia: the potential for TNF antagonism

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Immune and neurohormonal pathways in chronic heart failure

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Ghrelin improves left ventricular dysfunction and cardiac cachexia in heart failure

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

The impact of cachexia on cardiorespiratory reflex control in chronic heart failure

1 reference

https://api.crossref.org/works/10.1080%2F07853890410017467

21 January 2018

Identifiers

10.1080/07853890410017467

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35932382&oldid=1983346354"